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Abstract: Although 1,25-dihydroxyvitamin D [1,25(OH)2D] is the biologically active form of vitamin D, measurement of
the total serum 25-hydroxyvitamin D [25(OH)D] level is the gold standard used to define vitamin D status. Currently, it is
widely accepted that serum 25 (OH) D levels below 20 ng/ml defines vitamin D deficiency. According to this definition,
there appears to be pandemic vitamin D deficiency in the Black population. However, there is no evidence of higher-thannormal rates of common complications and symptomology of true vitamin D deficiency in the Black population. What is
going on? We researched the MEDLINE databases to find studies, from 1967 to present, that directly compare between
Blacks and Caucasians the following: serum vitamin D level, serum calcium level, serum parathyroid hormone level, bone
mineral density and health, and non-skeletal risks associated with vitamin D deficiency. The available studies consistently
show that Blacks tend to have serum 25(OH)D levels in the deficient range while their serum 1,25(OH)2D level is similar
to, if not even slightly higher than that of Caucasians, and that the serum Ca2+ level in Blacks is virtually identical to that
in Caucasians. Therefore, it appears that the serum 25(OH)D level is not the best marker of vitamin D sufficiency or
deficiency in Blacks. In the future, clinical evaluation of the vitamin D status in the Black population needs to consider
other serum biomarkers such as 1,25(OH)2D and/or bioavailable 25(OH)D.

Keywords: Black, deficiency, health, vitamin D.
INTRODUCTION
There are two sources of vitamin D for the human body:
diet and biosynthesis of vitamin D in the skin upon exposure
to adequate UV-B rays. As illustrated in Fig. (1), irradiation
of the epidermis of the skin by UV-B rays induces a nonenzymatic reaction that converts 7-dehydrocholesterol to
previtamin D. The previtamin D then undergoes a slow,
spontaneous conversion to vitamin D3. Vitamin D3 is
transported out of the skin and undergoes two rounds of
hydroxylation reactions; the first in the liver and the second
in kidney. In the liver, vitamin D3 is converted to 25(OH)D3
by the enzyme, 25-hydroxlylase. In the kidney, the
25(OH)D3 is converted to the biologically active
1,25(OH)2D3 by the enzyme, 25-hydroxycalciferol 1-αhydroxylase (1-α-hydroxylase) in the proximal convoluted
tubule [1]. Dietary sources contain vitamin D3 and vitamin
D2. Metabolism of vitamin D2 in the human body is the same
as that of vitamin D3. In general, hydroxylated metabolites of
vitamin D2 and vitamin D3 are simply referred to as
25(OH)D and 1,25(OH)2D. It should be noted that
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1,25(OH)2D is the biologically active vitamin D and that the
biological effect of 1,25(OH)2D on cells is mediated by the
vitamin D receptor (VDR), a specific ligand-dependent
nuclear transcription factor that regulates expression of a
large number of genes in many organs including bone,
muscle, pancreas, brain, the pituitary, and the immune
system [2, 3].
The melanin pigment is an excellent natural absorbent of
the UV-B radiation, and therefore dark-skinned people
require substantially more exposure to UV-B rays than fair
skinned people in order to synthesize an adequate amount of
vitamin D3 [4, 5]. Thus, dark-skinned people, such as Blacks
and dark skinned Indians, are more susceptible to developing
vitamin D deficiency in the absence of adequate sunlight
exposure or without taking vitamin D supplements [4-7]. The
significance of adequate sunlight exposure for the vitamin D
status in dark-skinned people is best illustrated by a recent
finding showing that those Africans, such as the Maasai and
Hadzabe people, who still maintain a hunter-gather life style
and get plenty of sunlight exposure, have a serum level range
of 25(OH)D at 43 ng/mL to 59 ng/mL [8], a concentration
range that can only be found in sunlight-replete Caucasians
lifeguards in the summer [9].
The conversion of 25(OH)D to 1,25(OH) 2D by the 1-hydroxylase in the kidney is strictly regulated (Fig. 1). The
activity of 1--hydroxylase is stimulated primarily by

2015 Bentham Open

6

The Open Nutrition Journal, 2015, 9,

parathyroid hormone (PTH) and inhibited by phosphate,
Ca2+, and fibroblast growth factor 23 (FGF23). In addition,
1--hydroxylase is subjected to feedback inhibitory
regulation by 1,25(OH)2D. At high concentrations,
1,25(OH)2D induces inhibition of its own synthesis by downregulating 1--hydroxylase activity in the kidney and
activating vitamin D 24 hydroxylase in peripheral tissues
(Fig. 1). The 24-hydroxylase hydroxylates both 25(OH)D
and 1,25(OH)2D on the #24-carbon to yield biologically
inactive 24-hydroxyl derivatives, 24,25-dihydroxy-vitamin D
[24,25(OH)2D] and 1,24,25-trihydroxyvitamin D [1,24,25
(OH)3D] [11, 12]. The combined actions of PTH, FGF23,
1,25(OH)2D, Ca2+ and phosphate on the vitamin D metabolic
enzymes lead to homeostasis of 1,25(OH)2D, which is
important for the maintenance of calcium and phosphate
homeostasis in the blood.
The classical function of vitamin D is to regulate calcium
and phosphorus homeostasis in the blood, which is critical
for bone health. Thus, clinical determination of vitamin D
status is largely based on the relationship between serum
25(OH)D level and bone disorders [13]. However,
epidemiological studies have linked vitamin D deficiency
with a plethora of negative health outcomes, including
cardiovascular diseases, immune dysfunction, cancer,
reproductive disorders, neurological disorders, and metabolic
syndromes [13-16]. The action mechanism of the
biologically active vitamin D, 1,25(OH)2D, involves nuclear
vitamin D receptor (VDR) which is ubiquitously expressed
and acts as ligand-dependent transcription factor that
regulates the promoters of vitamin D target genes via
binding to the vitamin D responsive element (VDRE) in the
promoters of these genes [17]. Most cell types in the human

Fig. (1). Metabolism of vitamin d in human body.
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body appear to respond to 1,25(OH)2D stimulation, and a
large number of the genes in the human genome are
regulated by 1,25(OH)2D [2, 3]. In this context, it is
frightening to see that up to 82.1% Blacks in the US are
considered to be vitamin D deficient as defined by less than
20 ng/mL 25(OH)D in the serum [18]. Fortunately, there is
no evidence of high rates of medical complications and
symptomology of true vitamin D deficiency in the US Black
population. What is going on? To understand it, we
researched the MEDLINE databases to find studies, from
1967 to present, that directly compare between Blacks and
Caucasians the following: serum vitamin D level, serum
calcium level, serum parathyroid hormone level, bone
mineral density and health, and non-skeletal risks associated
with vitamin D deficiency. To our knowledge, this is the first
attempt to systematically review the biomedical literature
concerning specifically the vitamin D status in Blacks. In
this review, we report on the available information and
suggest that this pandemic vitamin D deficiency in the black
population is a false alarm, because most Blacks of both
genders and at all age groups have healthy serum levels of
the biologically active 1,25(OH)2D and they are functionally
vitamin D sufficient despite the fact that their serum
25(OH)D levels are in the deficient range.
REVIEW OF EVIDENCE
Blacks Are Deficient in 25(OH)D but Replete with
1,25(OH)2D
In the blood circulation, up to 90% of 25(OH)D is bound
to vitamin D-binding proteins (VDBP), the rest is mostly
bound to albumin, and less than 1% remains free [10]. The
25(OH)D circulates in the blood at ng/mL concentrations
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and has a half-life of approximately 15 days whereas the
1,25(OH)2D circulates at pg/mL concentrations and has a
half-life of approximately 15 hours [19-21]. Even though
1,25(OH)2D is the biologically active form of vitamin D,
determination of vitamin D status has been all about
measuring the total serum levels of 25(OH)D for both
technical convenience and the fact that the serum level of
25(OH)D is largely proportional to the serum level of
1,25(OH)2D in the general non-black population. The
available studies have consistently demonstrated that many
Blacks of both genders and at all life stages – neonates,
preadolescents, adolescents, middle ages, and old ages –
have serum 25(OH)D levels in the ranges of deficiency
(Table 1). However, studies that have directly compared the
serum levels of both 25(OH)D and 1,25(OH)2D between
Blacks and Caucasians consistently found that the serum
1,25(OH)2D level in Blacks is similar if not even slightly
higher than that in Caucasians, notwithstanding the
deficiencies of 25(OH)D (Table 1). These data indicate that
Blacks are by large replete with the biologically active
vitamin D and therefore are not functionally vitamin D
deficient and that low serum 25(OH)D level in Blacks is not
indicative of vitamin D deficiency.

to the total amount of 25(OH)D in Caucasians; (ii) Blacks
have vitamin D deficiency as defined by the low serum
25(OH)D level; (iii) Blacks have lower serum VDBP level
than Caucasians; and (iv) the serum bioavailable 25(OH)D
level in Blacks is similar to that of Caucasians after adjusting
the VDBP-bound 25(OH)D. This study explains that one
reason why Blacks have healthy levels of serum 1,25(OH)2D
is because they have adequate levels of bioavailable
25(OH)D in the serum due to decreased serum VDBP level.
Hence, it appears that although it is not necessary for
Caucasians, a measurement of the serum 1,25(OH)2D level
or the amount of the bioavailable 25(OH)D in the serum
would more accurately determine vitamin D sufficiency or
deficiency in the Black population. This is very important
given the fact that these days taking high doses of oral
vitamin D supplements is the norm of life for people who are
diagnosed to be vitamin D deficient, and that excessive
intake of vitamin D has the potential to cause chronic toxic
effects of hypervitaminosis D, which presents as
hypercalcemia and renal damage [23-25]. It is not
unreasonable to think that treatment of the traditionally
determined “vitamin D deficient” Blacks may cause a severe
toxicity of hypervitaminosis D.

Bioavailability of Serum 25(OH)D in Blacks

PTH Status, Calcium Homeostasis and Bone Health in
Blacks

The commonly used assays that determine the
concentrations of vitamin D in the serum measure total
circulating 25(OH)D without distinguishing the free vitamin
D from the vitamin D bound to vitamin D binding protein
(VDBP) and albumin. Recently, Powe et al. [22] determined
and compared the amounts of bioavailable 25(OH)D – that
is, the amount of serum 25(OH)D not bound to VDBP –
between Blacks and Caucasians and found the following: (i)
the amount of bioavailable serum 25(OH)D is proportional
Table 1.

The classical function of 1,25(OH)2D is its ability to act
in the intestine to stimulate the absorption of calcium and
phosphorous, and in the kidney to stimulate the reabsorption
of calcium and phosphorus. Thus, chronic deficiency of
1,25(OH)2D in the body due to various reasons, such as lossof-function mutations in 1--hydroxylase deficiency and
hypoparathyroidism, results in bone disorders, such as
rickets, osteoporosis and osteomalacia. Elevation of the
blood PTH level is a normal physiological response to

Comparison of the mean blood levels of 25(OH)D, 1,25(OH)2D, PTH, and calcium (Ca2+) in caucasians and blacks.

25(OH)D (ng/mL)

1,25(OH)2D (pg/mL)

PTH (pg/mL)

Serum Ca2+ (mM)
Subject Characteristics

Reference

N/A

Peripubertal females

[44]

N/A

N/A

Adult females

[46]

47.08

4.125

2.29

Adult females

[48]

24.9

28.0

2.38

2.32

Young females

[49]

40.38

23.58

35.83

2.32

2.29

Adult males and females

[34]

28.43

28.03

30.27

37.15

1.20

1.21

Adult females

[33]

11.71

31.45

32.22

N/A

N/A

N/A

N/A

Neonates

[47]

32.6

20.4

N/A

N/A

N/A

N/A

N/A

N/A

Adult males

29.3

19.1

N/A

N/A

N/A

N/A

N/A

N/A

Adult females

36.66

21.15

N/A

N/A

N/A

N/A

N/A

N/A

Adolescent males

39.54

16.23

N/A

N/A

N/A

N/A

N/A

N/A

Adolescent females

Caucasian

Black

Caucasian

Black

Caucasian

Black

Caucasian

Black

29.9

18.5

N/A

N/A

36.6

40.9

N/A

27.16

13.1

N/A

N/A

35.9

39

31.2

14.8

N/A

N/A

38.89

33.2

25.7

36.0

45.4

18.4

10.8

37.31

25.5

13.8

17.41

[22]

[45]
The details of the statistical analysis of the data shown here can be found in the original studies. N/A: not available
Normal PTH levels: 15-60 pg/ml
Normal calcium levels: 2.0-2.6 mM
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decreased calcium level in the blood. The primary functions
of PTH include stimulation of bone resorption by osteoclasts
to release calcium from the bone and stimulation of 1-hydroxylase in the kidney to increase the production of
1,25(OH)2D, which in turn stimulates intestinal absorption of
calcium and renal reabsorption of calcium.
In comparison to the serum PTH level in Caucasians, the
serum PTH level in Blacks are approximately 15% higher, a
common findings in different studies (Table 1). However,
the serum Ca2+ level in Blacks is in the normal range and
virtually identical to that of Caucasians (Table 1), indicating
that the elevated serum PTH level in Blacks is not indicative
of clinical hyperparathtyroidism because hypercalcemia
normally occurs as a result of hyperparathyroidism [26-28].
Although high serum PTH level increases the risk of
accelerated rate of bone resorption and bone disorders in
Caucasians, the higher serum PTH level in Blacks actually
does not seem to cause bone disorders. As a matter of fact,
Blacks actually have higher bone mass density (BMD),
higher bone strength and less risk of bone fracture than
Caucasians as shown in studies conducted by DawsonHughes et al. [29] and Hochberg [30]. For example, the risk
that a postmenopausal Caucasian woman having a hip
fracture by age 80 is 11% compared with only 4% for a
Black woman [31, 32]. Apparently, the higher PTH level
does not cause faster bone turnover in Blacks possibly as a
result of bone resistance to PTH [33, 34]. This bone
resistance to PTH is likely to be beneficial to the health of
the skeletal system in Blacks since it prevents PTH from
overly stimulating bone resorption when serum PTH level is
high. Nevertheless, the relationship between serum PTH
level and vitamin D metabolism seems greatly different
between Blacks and Caucasians [35].
Effect of 1,25(OH)2D on Serum PTH Level in both Blacks
and Caucasians
True vitamin D deficiency can decrease the serum
calcium level, which in turn can cause secondary
hyperparathyroidism and increased bone resorption [27].
Thus, the increase of serum PTH level is a normal
compensatory mechanism in response to a decreasing serum
calcium concentration. But, why do Blacks have elevated
serum PTH level and yet their serum levels of Ca2+ are
within the normal range? The answer to this question is
provided by a study involving female Black and Caucasian

Table 2.

subjects matched with ages and body-mass index. In this
study, the subjects received 0.25 g 1,25(OH)2D four times a
day for 2 weeks. At the end of this study, it was found that
the treatment virtually had no effect on the serum levels of
25(OH)D and Ca2+, it increased the serum 1,25(OH)2D level,
and it significantly decreased the serum PTH level in all
subjects (Table 2) [29]. Furthermore, this study
demonstrated that the treatment caused the average serum
levels of 1,25(OH)2D in these female Caucasians and Blacks
to be increased to an almost identical level (40.54 + 3.65
pg/mL in Caucasians vs 41.73 + 3.85 pg/mL in Blacks), and
yet the post treatment level of PTH still remained higher in
Blacks than in Caucasians: the pretreatment PTH levels are
31.7 + 3.8 pg/mL in Caucasians vs 48.1 + 4.0 pg/mL in
Blacks and the post treatment PTH levels are 23.4 + 3.6
pg/mL in Caucasians vs 33.9 + 3.7 pg/mL in Blacks (Table
2). These findings demonstrated two important points: first,
these Black women maintain a higher level of serum PTH
than Caucasian women do even when their serum
1,25(OH)2D levels are almost identical; second, changes in
the serum levels of PTH is unrelated to the status of calcium
and 25(OH)D but directly related to the 1,25(OH)2D level in
the blood. Since PTH directly affects the production of
1,25(OH)2D in the kidney by increasing the level of renal
1α-hydroxylase [36] and since 1,25(OH)2D can directly
induce suppression of the expression of PTH gene in and
secretion of PTH from the human parathyroid glands [37], it
is plausible that there is a Ca2+-independent 1,25(OH)2D →
PTH regulatory loop that regulates the serum 1,25(OH)2D
level. Thus, PTH would stimulate 1--hydroxylase for
1,25(OH)2D synthesis and at high concentrations,
1,25(OH)2D would exert a feedback inhibitory effect on the
expression of PTH gene in and secretion of PTH from the
parathyroid glands in a Ca2+-independent manner. However,
there is likely a caveat about this 1,25(OH)2D → PTH loop
in Blacks – that is, like the bone resistance to PTH [33, 34],
there could also be kidney resistance to PTH in Blacks. Such
a kidney desensitization to PTH can explain why the serum
PTH level in Blacks is higher than that in Caucasians even
when the 1,25(OH)2D levels are almost identical in both
groups because higher levels of PTH are needed to maintain
an adequate level of the 1--hydrolylase in the kidney to
maintain sufficient amount of 1--hydroxlylase for the
synthesis of the same amount of 1,25(OH)2D in the bodies of
Blacks. However, future research involving more subject and
subjects of both genders and at different age groups is
needed to investigate this possibility.

Effects of 1,25(OH)2D treatment on the serum levels of 25(OH)D, 1,25(OH)2D, PTH, and calcium (Ca2+) in adult female
caucasians and blacks.

Conditions

25(OH)D (ng/mL)

1,25(OH)2D (pg/mL)

PTH (pg/mL)

Serum Ca2+ (mM)

Caucasian

Blacks

Caucasian

Blacks

Caucasian

Blacks

Caucasian

Blacks

Before
treatment

35.4 (+ 3.7)

19.8(+ 3.9)

30.08 (+ 2.38)

36.81 (+ 2.46)

31.7 (+ 3.8)

48.1 (+4.0)

2.24 (+ 0.02)

2.21 (+ 0.02)

After
treatment

38.7 (+ 4.9)

21.7 (+5.2)

40.54 (+ 3.65)

41.73 (+ 3.85)

23.4 (+ 3.6)

33.9 (+3.7)

2.27 (+ 0.02)

2.23 (+ 0.02)

Refere
nce

[29]

Normal PTH levels: 15-60 ng/ml
Normal calcium levels: 2.0-2.6 mM
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Vitamin D Status and the Risks of Non-skeletal Diseases
in the Black Population
Various epidemiological studies have associated low
serum 25(OH)D level with negative health outcomes in the
general population [13-16]. In addition to causing bone
disorders, vitamin D deficiency is also associated with
increased risks of developing stroke, coronary heart disease,
premenstrual syndrome, chronic kidney disease, and systolic
high blood pressure in Caucasians (Table 3). However, direct
comparison between Caucasians and Blacks indicate that
Blacks are relatively protected from the numerous clinical
complications of the non-skeletal systems (Table 3).
DISCUSSION
In general, vitamin D deficiency is defined as the serum
level of 25(OH)D lower than 20 ng/mL and closely
associated with clinical bone disorders, such as rickets,
osteomalacia and osteoporosis. However, this classification
of vitamin D deficiency is most unlikely to be applicable to
Blacks because they have healthy serum levels of the
biologically active 1,25(OH)2D and calcium at all life stages
despite the fact that their serum 25(OH)D level is in the
range of deficiency. Blacks also do not present with high
rates of the various skeletal and non-skeletal clinical
complications associated with true vitamin D deficiency
(Tables 1 and 3). Therefore, the low serum 25(OH)D level
and normal serum 1,25(OH)2D level in Blacks are indicative
of functional vitamin D sufficiency. This feature is rather
unique to Blacks because the serum 25(OH)D level is
proportional to the serum level of 1,25(OH) 2D and
deficiency of 25(OH)D is indicative of functional vitamin D
deficiency in people of other races. For instance, the high
rate of vitamin D deficiency in the Indian population is
closely associated with high incidences of bone disorders
[50]. Nevertheless, we believe determination of the vitamin
D status in Blacks in the future should use test results that
show the serum levels of bioavailable 25(OH)D and
1,25(OH)2D.
A study by Signorello et al. determined serum 25(OH)D
level of an African American population in the context of the
African ancestry based on the analysis of a panel of 276
ancestry informative SNPs found that, with increasing
African ancestry, there is a linear statistically significant
decrease in the serum level of 25(OH)D [38]. In this study,
individuals with high African ancestry, (>95%) have 16.5
Table 3.
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ng/mL 25(OH)D whereas people with lower African
ancestry, (<85%) have 1.2 times more circulating 25(OH)D.
It is most likely that the evolution of African people has
selected an adaptive compensatory mechanism to cope with
a reduced synthesis of previtamin D in the skin due to skin
hyperpigmentation that reduces the amount of UV-B
radiation that could reach the epidermis [5, 39]. This
compensatory mechanism maximizes the synthesis and
maintenance of optimal serum levels of 1,25(OH)2D in the
face of low serum 25(OH)D level. The outcome is successful
maintenance of calcium homeostasis and the health of the
skeletal system as well as the non-skeletal systems. It is most
likely that the evolution of this mechanism has involved the
selection of multiple changes. First, there is the lowering of
the concentrations of VDBP in the blood to increase the
bioavailability of 25(OH)D for the synthesis of 1,25(OH) 2D
[22]. Second, there is elevation of the serum PTH to high
enough levels to perhaps stimulate and maintain high
amounts of 1--hydrolylase in the kidney for the synthesis of
adequate amounts of 1,25(OH)2D. Yet, the levels of PTH are
not too high to causes bone resorption and complications of
hyperparathyroidism. Third, the 24-hydroxylase catalyzes
the conversion of 1,25 (OH)2D into the inactive intermediate
1,24,25(OH)3D [12]. The 24-hydroxylase gene is normally
expressed at very low level, but its expression is strongly upregulated by 1,25(OH)2D [40]. It has been demonstrated that
a unique variant of the vitamin D responsive element
(VDRE) that weakens the transcriptional activity of the
promoter of the 24-hydroxylase gene exists in the Black
population [41]. The consequence of the presence of this
variant is that the expression of the 24-hydroxylase gene is
not so robust even in the presence of high concentrations of
1,25(OH)2D [41]. This change ensures slower rate of
inactivation of 1,25(OH)2D in Blacks.
CONCLUSION
In summary, it is critical to investigate why Blacks are
able to maintain a healthy serum 1,25(OH)2D level at all life
stages despite the fact that they have deficient 25(OH)D
level (Table 1). Accurate determination of vitamin D status
in Blacks will be beneficial for the management of their
overall health since true vitamin D deficiency is correlated
to, if not the cause of, a long list of negative health
outcomes, including premature mortality, cancers,
autoimmune diseases, diabetes, chronic musculoskeletal
pain, neurological and cognitive disorders, depression, dental

Relationship between various disease risk and low levels of 25(OH)D in caucasians and blacks.
Risk Associated with Low 25(OH)D Level

Diseases

Reference
Caucasian

Blacks

Stroke

Increased risk

No apparent association

[51]

CHD

Increased risk

No apparent association

[52]

PMS

No apparent association

No apparent association

[53]

CKD

Increased fatality

No apparent association

[54]

HBP

Increased risk

No apparent association

[55]

CHD: Coronary Heart Disease; PMS: Premenstrual Syndrome; CKD: Chronic Kidney Disease; HBP: systolic High Blood Pressure.
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disease and cardiovascular disease [42, 43]. It is therefore of
utmost importance that future research be focused on better
understanding of the mechanisms that regulate metabolism
of vitamin D and maintain a healthy serum 1,25(OH)2D level
in Blacks.
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